Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer

Prostate

Volumn 64, Issue 1, 2005, Pages 29-39

  Bjartell, Anders ^a   Paju, Annukka ^b   Zhang, Wan Ming ^b   Gadaleanu, Virgil ^a   Hansson, Jens ^a   Landberg, Göran ^a   Stenman, Ulf Håkan ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Immunohistochemistry; In situ hybridization; Kallikreins; Proteases; RT PCR

Indexed keywords

DNA; TRYPSINOGEN; TUMOR ASSOCIATED TRYPSINOGEN 1; TUMOR ASSOCIATED TRYPSINOGEN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BENIGN TUMOR; BONE METASTASIS; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METRIBOLONE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARACRINE COMMUNICATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRYPSIN; TRYPSINOGEN;

EID: 19544392857     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20236     Document Type: Article

References (49)

1. Guy O, Lombardo D, Bartelt DC, Amic J, Figarella C. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry 1978;17:1669-1675.
2. Koivunen E, Huhtala ML, Stenman UH. Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of prourokinase. J Biol Chem 1989;264:14095- 14099.
3. Bohe M, Borgström A, Lindström C, Ohlsson K. Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol 1986;39:786-793.
4. Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H, Miyazaki K. Expression of trypsin in vascular endothelial cells. FEBS Lett 1997;409:442-448.
5. Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H, Miyazaki K. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 1998;153:937-944.
6. Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L, Miyazaki I. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br J Cancer 1994;69:152-156.
7. Terada T, Ohta T, Minato H, Nakanuma Y. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 1995;26:746-752.
8. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K, Kitamura H. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: An immunohistochemical study. Hum Pathol 1997;28:613-622.
9. Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, Elnemr A, Miwa K, Nakanuma Y. Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 1998;69:71-75.
10. Oyama K, Ohta T, Nishimura GI, Elnemr A, Yasui T, Fujimura T, Fushida S, Kitagawa H, Kayahara M, Terada T, Miwa K. Trypsinogen expression in colorectal cancers. Int J Mol Med 2000;6:543-548.
11. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML, Stenman UH. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 1991;47:592-596.
12. Miszczuk-Jamska B, Merten M, Guy-Crotte O, Amouric M, Clemente F, Schoumacher RA, Figarella C. Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1. FEBS Lett 1991;294:175-178.
13. Koshikawa N, Yasumitsu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 1992;52:5046-5053.
14. Koivunen E, Itkonen O, Halila H, Stenman UH. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res 1990;50:2375-2378.
15. Hirahara F, Miyagi E, Nagashima Y, Miyagi Y, Yasumitsu H, Koshikawa N, Nakatani Y, Nakazawa T, Udagawa K, Kitamura H, Minaguchi H, Miyazaki K. Differential expression of trypsin in human ovarian carcinomas and low-malignant-potential tumors. Gynecol Oncol 1998;68:162-165.
16. Miyata S, Miyagi Y, Koshikawa N, Nagashima Y, Kato Y, Yasumitsu H, Hirahara F, Misugi K, Miyazaki K. Stimulation of cellular growth and adhesion to fibronectin and vitronectin in culture and tumorigenicity in nude mice by overexpression of trypsinogen in human gastric cancer cells. Clin Exp Metastasis 1998;16:613-622.
17. Kato Y, Nagashima Y, Koshikawa N, Miyagi Y, Yasumitsu H, Miyazaki K. Production of trypsins by human gastric cancer cells correlates with their malignant phenotype. Eur J Cancer 1998;34:1117-1123.
18. Tajima H, Ohta T, Elnemr A, Yasui T, Kitagawa H, Fushida S, Kayahara M, Miwa K, Wakayama T, Iseki S, Yokoyoama S. Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA. Int J Cancer 2001;94:699-704.
19. Nyberg P, Moilanen M, Paju A, Sarin A, Stenman U-H, Sorsa T, salo T. MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res 2002;81: 831-835.
20. Yamamoto H, Iku S, Itoh F, Tang X, Hosokawa M, Imai K. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer 2001;91:1324-1331.
21. Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, Nosho K, Min Y, horiuchi S, Yoshida M, Itoh F, Imai K. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003;199:176-184.
22. Paju A, Bjartell A, Zhang W-M, Nordling S, Borgström A, Hansson J, Stenman U-H. Expression and characterization of trypsinogen produced in the male genital tract. Am J Pathol 2000;157:2011-2021.
23. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Investig Urol 1979;17:159-163.
24. Deperthes D, Chapdelaine P, Tremblay RR, Brunet C, Berton J, Hébert J, Lazure C, Dubé J. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta 1995;1245:311-316.
25. Kirchheimer J, Koller A, Binder B. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue. Biochim Biophys Acta 1984;797:256-265.
26. Stamey T, Warrington J, Caldwell M, Chen Z, Fan Z, Mahadevappa M, McNeal J, Nolley R, Zhang Z. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 2001;166:2171-2177.
27. Stearns M, Stearns M. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 1996;8:69-75.
28. Knox J, Wolf C, McDaniel K, Clark V, Loriot M, Bowden G, Nagle R. Matrilysin expression in human prostate carcinoma. Mol Carcinog 1996;15:57-63.
29. Hamdy F, Fadlon E, Cottam D, Lawry J, Thurrell W, Silcocks P, Anderson J, Williams J, Rees R. Matrix metalloproteinase 9 expression in primary humanprostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1994;69:177-182.
30. Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkilä P, Tschesche H, Leinonen J. Activation of type IV pro-collagenases by human tumor-associated trypsin-2. J Biol Chem 1997;272:21067-21074.
31. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, Okada Y. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. Journal Of Biological Chemistry 1995;270:6691-6697.
32. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasmino-gen activator system in cancer metastasis: A review. Int J Cancer 1997;72:1-22.
33. Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 1999;13:781-792.
34. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman UH. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-718.
35. Lilja H, Christensson A, Dahlen U, Matikainen M, Nilsson O, Pettersson K, Lövgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37:1618-1625.
36. Emi M, Nakamura Y, Ogawa M, Yamamoto T, Nishide T, Mori T, Matsubara K. Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene 1986;41:305-310.
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guani-dinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
38. Lukkonen A, Lintula S, von Boguslawski K, Carpen O, Ljungberg B, Landberg G, Stenman UH. Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer 1999;83:486-490.
39. Moilanen M, Sorsa T, Stenman M, Nyberg P, Lindy O, Vesterinen J, Paju A, Konttinen Y, Stenman U-H. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-13) and degrades type I collagen. Biochemistry 2003;42:5414-5420.
40. Udayakumar TS, Chen ML, Bair EL, von Bredow DC, Cress AE, Nagle RB, Bowden G. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 {beta}3 chain and induces cell migration. Cancer Res 2003;63:2292-2299.
41. Nguyen T, Moody M, Steinhoff M, Okolo C, Koh D, Bunnett N. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 1999;103: 261-269.
42. Miyata S, Koshikawa N, Yasumitsu H, Miyazaki K. Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem 2000;275:4592-4598.
43. D'Andrea MR, Derian CK, Santulli RJ, Andrade-Gordon P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol 2001;158:2031-2041.
44. Uchima Y, Sawada T, Nishihara T, Umekawa T, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Identification of a trypsinogen activity stimulating factor produced by pancreatic cancer cells: Its role in tumor invasion and metastasis. Int J Mol Med 2003;12:871-878.
45. Greenberg D, Mize G, Takayama T. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. Biochemistry 2003;42:702-709.
46. Li Y, Sarkar F. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 2002;186:157-164.
47. Koistinen H, Paju A, Koistinen R, Finne P, Lövgren J, Wu P, Seppälä M, Stenman U-H. Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate 2002;50:112-118.
48. Iwamura M, Sluss P, Casamento J, Cockett A. Insulin-like growth factor I: Action and receptor characterization in human prostate cancer cell lines. Prostate 1993;22:243-252.
49. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E. Insulin-like growth factor-I (IGF-1) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002;94:1099-1106.